Cu/TI exhibits prolonged blood circulation and high tumor uptake to induce immunogenic cancer cell death and reduce PD‐L1 expression in vivo, thereby effectively enhancing the infiltration and activation of cytotoxic T lymphocytes to elicit potent antitumor effects in mouse models without causing obvious side effects. The gene discussed is CD274; the disease is cancer.